Current Status of Tricuspid Valve Interventions in Asia Pacific Region
Issued Date
2025-01-01
Resource Type
eISSN
27723747
Scopus ID
2-s2.0-85214322303
Journal Title
JACC: Asia
Rights Holder(s)
SCOPUS
Bibliographic Citation
JACC: Asia (2025)
Suggested Citation
So K.C.y., Xu J., Kam K.K.h., Sung S.H., Meemook K., Wang D.D., Tang G.H.L., Lee A.P.w., Lam Y.y. Current Status of Tricuspid Valve Interventions in Asia Pacific Region. JACC: Asia (2025). doi:10.1016/j.jacasi.2024.10.008 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/102746
Title
Current Status of Tricuspid Valve Interventions in Asia Pacific Region
Corresponding Author(s)
Other Contributor(s)
Abstract
Transcatheter tricuspid interventions are becoming increasingly more common in Asia Pacific. In the past decade, clinicians in Asia Pacific have worked with a multitude of new transcatheter tricuspid technologies. A standardized clinical algorithm to diagnose symptomatic tricuspid regurgitation to increase patient access to novel right heart therapies has not yet been identified. Anatomic diversity in the Asia Pacific patient population; disease prevalence patterns; and socioeconomic, cultural, and local health structures represent unique challenges in the treatment of these patients with right heart failure. As advancements are made in right heart failure and transcatheter tricuspid technologies, hopefully more patients can be treated not just in Asia Pacific, but across the entire world.